OTC Throat Lozenges Recalled for Temperature Storage Deviation
Ricola Cherry Honey Herb Throat Drops are recalled because products in batch 2000058693 were exposed to temperatures outside the labeled storage conditions during distribution. The Class II recall affects nationwide shipments.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for a manufacturing deviation (temperature exposure) with no reported illnesses or injuries. The hazard is a theoretical loss of product efficacy due to improper storage conditions, not an active safety threat.
Plain-English summary
Ricola Cherry Honey Herb Throat Drops (menthol 1.8 mg per drop, 10 drops per roll) are being recalled due to Current Good Manufacturing Practices (CGMP) deviations. Products in batch 2000058693 were exposed to temperatures outside the range specified on the product label during storage or distribution.
The recalled products were manufactured by Ricola Ltd. (4242 Laufen, Switzerland) and distributed nationwide by Ricola USA Inc. (Parsippany, NJ). The affected product carries NDC 54305-507-10 and UPC 0036602074507.
No illnesses or injuries have been reported. Consumers who have purchased this product should verify the batch number. If the batch matches 2000058693, the product may no longer meet quality standards and should be discarded.
The recalled product
- Product
- NATURAL CHERRY HONEY HERB THROAT DROPS (MENTHOL)
- Brand
- NATURAL CHERRY HONEY HERB THROAT DROPS
- Manufacturer
- CARDINAL HEALTHCARE
- Category
- Drug — OTC / Throat Lozenges
- Hazard
- storage-deviation
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch 2000058693
UPCs (1)
- 0036602074507
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27